Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 378

1.

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P.

Rheumatology (Oxford). 2006 Jan;45(1):106-11.

2.
3.
4.

The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.

Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB.

Semin Arthritis Rheum. 2004 Feb;33(4):283-8.

PMID:
14978666
5.

Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs.

Kapetanovic MC, Roseman C, Jönsson G, Truedsson L.

Clin Rheumatol. 2011 Dec;30(12):1555-61. doi: 10.1007/s10067-011-1856-5.

PMID:
21956234
6.

Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.

Visvanathan S, Keenan GF, Baker DG, Levinson AI, Wagner CL.

J Rheumatol. 2007 May;34(5):952-7.

PMID:
17444589
7.

Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept.

Mease PJ, Ritchlin CT, Martin RW, Gottlieb AB, Baumgartner SW, Burge DJ, Whitmore JB.

J Rheumatol. 2004 Jul;31(7):1356-61.

PMID:
15229957
8.

Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine.

Gelinck LB, van der Bijl AE, Visser LG, Huizinga TW, van Hogezand RA, Rijkers GT, Kroon FP.

Vaccine. 2008 Jun 25;26(27-28):3528-33. doi: 10.1016/j.vaccine.2008.04.028.

PMID:
18502006
9.

Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Jiuchi Y, Kozuru H, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Kitagawa K, Takahi K, Ozawa T, Hamada N, Nakajima K, Nagai H, Tamura N, Suenaga Y, Kawabata M, Matsui T, Furukawa H, Kawakami K, Oishi K.

Medicine (Baltimore). 2015 Dec;94(52):e2184. doi: 10.1097/MD.0000000000002184. Erratum in: Medicine (Baltimore). 2016 Feb;95(8):e8362. Oish, Kazunori [Corrected to Oishi, Kazunori].

10.

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Kozuru H, Jiuchi Y, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Takahi K, Yoshizawa S, Kawabe Y, Suenaga Y, Ozawa T, Hamada N, Komiya Y, Matsui T, Furukawa H, Oishi K.

Arthritis Res Ther. 2015 Dec 10;17:357. doi: 10.1186/s13075-015-0863-3.

11.

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.

14.

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Sugiyama T, Kawabe Y, Katayama M, Suenaga Y, Okamoto A, Ohshima H, Okada Y, Ichikawa K, Yoshizawa S, Kawakami K, Matsui T, Furukawa H, Oishi K.

Arthritis Res Ther. 2015 Jun 3;17:149. doi: 10.1186/s13075-015-0662-x.

15.
16.

[Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].

Tijhuis GJ, van de Putte LB, Breedveld FC.

Ned Tijdschr Geneeskd. 2001 Sep 29;145(39):1880-5. Review. Dutch.

PMID:
11605312
17.

Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A.

Arthritis Rheum. 2010 Jan;62(1):64-74. doi: 10.1002/art.25034.

18.

The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.

van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ; Etanercept Study 400 Investigators..

Ann Rheum Dis. 2008 Feb;67(2):182-8.

PMID:
17728331
19.

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.

Crnkic Kapetanovic M, Saxne T, Jönsson G, Truedsson L, Geborek P.

Arthritis Res Ther. 2013 Oct 30;15(5):R171. doi: 10.1186/ar4358.

20.

Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.

Aikawa NE, França IL, Ribeiro AC, Sallum AM, Bonfa E, Silva CA.

Vaccine. 2015 Jan 29;33(5):604-9. doi: 10.1016/j.vaccine.2014.12.030.

PMID:
25554240
Items per page

Supplemental Content

Support Center